ZILARTA CT 40/12.5 (Azilsartan medoxomil (40mg) + Chlorthalidone (12.5mg))

Zilarta-CT 40/12.5 Tablet is a pharmaceutical formulation designed to assist in managing hypertension, which is characterized by elevated blood pressure levels. This combination medication operates by relaxing blood vessels, thereby enhancing the efficiency of the heart in pumping blood throughout the body. Additionally, it functions by eliminating excess fluids and specific electrolytes from the system. The tablet can be administered with or without food, but consistency in timing is recommended to maximize its effectiveness. It is crucial to adhere to the dosage and frequency as prescribed by your healthcare provider, as these will vary depending on the condition being treated. Patients are advised against skipping doses and should complete the entire treatment course, even if symptoms improve. Abrupt cessation of the medication should only be done under medical guidance to prevent a possible exacerbation of symptoms. While on this medication, maintaining adequate hydration is essential. Side effects may include fatigue, low potassium levels, reduced blood pressure, heightened creatinine levels, and increased uric acid levels. Monitoring of blood pressure should be conducted regularly during treatment to ensure safety and effectiveness. Prior to initiation of therapy, individuals should inform their healthcare provider of any past circulatory issues or existing liver or kidney conditions. Furthermore, it is important to disclose all current medications, as interactions could alter the efficacy of Zilarta-CT.